ReShape Lifesciences Inc. (RSLS)

0.65 -0.06 (-8.451%)

IEX Real-Time Price

12:47:18 PM EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.71

Price Open 0.68

Volume: 263,158

Avg Volume: 2.29M

Market Cap: 2.05M

P/E Ratio -

52 Wk Range 0.62-3756.9



RSLS Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
82.4M
1.97M
0.27
2.39%

2018-09-28
82.4M
1.16M
0.22
1.41%

2018-09-14
60.36M
2.29M
0.32
3.79%

2018-08-31
53.85M
1.21M
0.11
2.24%




RSLS Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-14
Q3 2018
AMC
0.00 (0)
-27.46
0.00

2018-08-14
Q2 2018
AMC
0.00 (0)
-3.26
0.00

2018-05-15
Q1 2018
N/A
0.00 (0)
-0.56
0.00

2018-05-14
Q1 2018
AMC
0.00 (0)
-0.36
0.00

News

Healthcare & Tech dominate midday movers (2018-11-27 12:44 SeekingAlpha)

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more …

 


Statistics

Shares Outstanding: 3.16M

Top 15 Institution Percent: 192.10

Price To Sales: 0.89

Price To Book: 0.06

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -131.22

Return On Equity: -154.06

Profit Margin: N/A

Price History

Beta: 1.75

50-day Moving Avg: 3.16

200-day Moving Avg: 727.17

YTD Change: -99.98

5-day Change: -17.92

1-month Change: -60.34

3-month Change: -91.42

6-month Change: -99.86

1-year Change: -99.98

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: ReShape Lifesciences Inc.

Exchange: NASDAQ Capital Market

Industry: Medical Devices

Sector: Healthcare

Website: https://www.reshapelifesciences.com

Reshape Lifesciences Inc is a medical device company. The company is focused on the design and development of devices which use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.